Company Profile
Updated: 26-OCT-09Active Biotech AB
International public company
PO Box 724, Scheelevaegen 22, Lund, S-220 07, Sweden
()46 046 19 20 00, 46 046 19 11 00 fax, http://www.activebiotech.com
Primary SIC: Medical Chemicals & Botanical Products, Primary NAICS: Medicinal and Botanical Manufacturing
Description: Manufacturing: Biotechnology company focused on the research and development of pharmaceuticals within the ares of autoimmunity/inflammation and cancer
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Research and Markets: Competitor Analysis: FGF-R Agonists and Antagonist - A Compilation of Current Active Projects in Research and Development of Molecules Targeting FGF.
Business Wire; 11/5/2009; 1198 words; ...platelets. The report includes a compilation of current active projects in research and development of molecules...PDGF-R Agonist and Antagonist R&D Pipelines: * AB Science * Accelera * ACT Biotech * Advenchen Laboratories * Ambrx * Amgen * Ariad...
Other News To Note.
BIOWORLD Today; 11/4/2009; 1851 words; Active Biotech AB, of Lund, Sweden, selected a candidate drug, ABR-215757, within the systemic lupus erythematosus project (SLE) for clinical...
Perrigo Announces Dismissal of Duac Patent Litigation.
Biotech Week; 11/4/2009; 860 words; ...affordable." This product is the AB-rated equivalent to Stiefel...pharmaceuticals, nutritional products, active pharmaceutical ingredients...This article was prepared by Biotech Week editors from staff and other reports. Copyright 2009, Biotech Week via NewsRx.com.
Perrigo Announces Dismissal of Duac[R] Patent Litigation.
Biotech Week; 11/4/2009; 741 words; ...affordable." This product is the AB-rated equivalent to Stiefel...pharmaceuticals, nutritional products, active pharmaceutical ingredients...This article was prepared by Biotech Week editors from staff and other reports. Copyright 2009, Biotech Week via NewsRx.com.
Clinic Roundup.
BIOWORLD Today; 11/3/2009; 1236 words; o Active Biotech AB, of Lund, Sweden, reported data from an interim analysis of the...treatment. The trial is expected to involve a total of 24 patients. Active Biotech anticipates starting Phase II/III studies next year. o Avidia Inc...
Recent News Articles
- Active Biotech AB - Financial and Strategic Analysis Review.
M2 Presswire - May 03, 2009 - Active Biotech AB appoints new CEO.
Nordic Business Report - July 23, 2008 - Q3 2007 Active Biotech AB Earnings Conference Call - Final.
Fair Disclosure Wire - November 08, 2007 - Teva/Active Biotech submit laquinimod IND.(Investigational New Drug)(Teva Pharmaceutical Industries Ltd)(Active Biotech AB)(Brief Article)
Pharma Marketletter - July 04, 2005
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning